Successful treatment of a primary central nervous system lymphoproliferative disorder post-heart transplantation with modification of the immunosuppressive regimen used: A case report

J Heart Lung Transplant. 2022 Feb;41(2):265-267. doi: 10.1016/j.healun.2021.10.009. Epub 2021 Oct 22.

¹ Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan; Department of Cardiology, Saitama Medical University, International Medical Center, Saitama, Japan.
² Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
³ Department of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
⁴ Department of Neurosurgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
⁵ Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan; Department of Cardiovascular Surgery, Saitama Medical University, International Medical Center, Saitama, Japan. Electronic address: nori@ncvc.go.jp.

No abstract available

Publication types